Stay updated on Pembrolizumab for Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.

Latest updates to the Pembrolizumab for Mesothelioma Clinical Trial page
- Check5 days agoChange DetectedThe study history now shows the latest revision as v3.6.5, replacing the previous v3.6.4, indicating a system or page update.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA new revision entry (v3.6.4) was added to the Study Record Versions, updating the history from the previous version (v3.6.3). This reflects a refresh of the page metadata in the record history.SummaryDifference0.1%

- Check48 days agoChange DetectedThe study record history shows a new revision (v3.6.3) replacing the previous version (v3.6.2) to reflect an update to the documented record.SummaryDifference0.1%

- Check55 days agoChange DetectedThe Record History shows the page revision updated to v3.6.2, replacing v3.6.0, indicating a maintenance release for the page history rather than changes to the study records.SummaryDifference0.1%

- Check69 days agoChange DetectedThe history now shows the trial is no longer recruiting participants, signaling the end of enrollment. It also records a new revision label v3.6.0 and removes the previous label v3.5.5 from the history.SummaryDifference0.4%

- Check77 days agoChange DetectedThe latest revision label in the study record history changed from v3.5.4 to v3.5.5, indicating an update to the page’s underlying record version.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mesothelioma Clinical Trial page.